- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04806984
Improving Gap Closure Rates Using a Predictive Model
March 24, 2023 updated by: NYU Langone Health
NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model.
The goal is to increase gap closure rate by the end of the year.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
34896
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- NYU Langone Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients in the NYU Langone network
Description
Inclusion Criteria:
- Patients in the NYU Langone network who are due for gaps in care.
Exclusion Criteria:
- Patients in the NYU Langone network are not due for gaps in care.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Call center phone call
Participants randomized to this arm will receive a phone call from the call center reminding them to schedule their appointments.
|
Participants in the experimental arms will receive a call center phone call or MyChart message to remind them to schedule their appointments.
|
|
No call center phone call
Participants randomized to this arm will not receive a phone call from the call center reminding them to schedule their appointments.
|
|
|
MyChart message
Participants randomized to this arm will receive an automated MyChart message reminding them to schedule their appointments.
|
Participants in the experimental arms will receive a call center phone call or MyChart message to remind them to schedule their appointments.
|
|
No MyChart message
Participants randomized to this arm will not receive an automated MyChart message reminding them to schedule their appointments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Gap closure rate
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Leora Horwitz, MD, NYU Grossman School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 9, 2021
Primary Completion (Actual)
February 27, 2022
Study Completion (Actual)
February 27, 2022
Study Registration Dates
First Submitted
March 5, 2021
First Submitted That Met QC Criteria
March 18, 2021
First Posted (Actual)
March 19, 2021
Study Record Updates
Last Update Posted (Actual)
March 28, 2023
Last Update Submitted That Met QC Criteria
March 24, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- QI-CIN Gaps Predictive Model
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Communication
-
Insel Gruppe AG, University Hospital BernSwiss National Science Foundation; University of Bern; Fachhochschule NordwestschweizRecruitingCommunication Research | Communication, MultidisciplinarySwitzerland, Austria
-
University of Wisconsin, MadisonUniversity of South Florida; University of Pittsburgh; University of Oklahoma; Duke... and other collaboratorsEnrolling by invitationCommunication Research | Communication ProgramsUnited States
-
Shanghai Zhongshan HospitalNot yet recruitingICU | Eye Tracking | Communication Barriers | Non-Verbal Communication
-
Bozok UniversityNot yet recruiting
-
Florida State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); Duquesne...CompletedSocial CommunicationUnited States
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruiting
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruitingTeacher Practice | Sign Language SkillsUnited States
-
Al-Hadba universityEnrolling by invitation
-
Izmir Democracy UniversityCompleted
Clinical Trials on Participant outreach
-
Women and Infants Hospital of Rhode IslandAdvance RI CTRRecruiting
-
Kaiser PermanenteRecruitingMultiple Chronic Conditions | Social Needs | Care Gaps | NavigationUnited States
-
University College DublinUnknown
-
Yale UniversityCompletedNutrition Disorders | Enteral FeedingUnited States
-
University of PennsylvaniaCompletedCancer of the Colon
-
Harvard Medical School (HMS and HSDM)Humana Co.Ltd.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
PfizerTerminatedHealthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune ThrombocytopeniaSpain, United States, Belgium, United Kingdom, New Zealand
-
AstraZenecaActive, not recruitingLung MalignancyMexico, Egypt, India, Indonesia, Turkey (Türkiye)
-
Kaiser PermanenteCompleted
-
University of California, DavisEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingSkin Pigment | Pulse OximetryUnited States